Niosomal delivery system for macromolecular drugs

Colloids in Drug Delivery

Volumn , Issue , 2016, Pages 355-364

  Huang, Yongzhuo ^a   Yu, Faquan ^a   Liang, Wenquan ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DELIVERY SYSTEMS; MACROMOLECULAR DRUGS;

DRUG DELIVERY;

EID: 79251524691     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Aggarwal, D. and Kaur, I. P. 2005. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int. J. Pharm., 290: 155-159.
2. Bandyopadhyay, P. and Johnson, M. 2007. Fatty alcohols or fatty acids as niosomal hybrid carrier: Effect on vesicle size, encapsulation efficiency and in vitro dye release. Colloids Surf. B Biointerfaces, 58:68-71.
3. Beugin, S., Edwards, K., Karlsson, G., Ollivon, M., and Lesieur, S. 1998. New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates. Biophys. J., 74: 3198-3210.
4. Brewer, J. M. and Alexander, J. 1992. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology, 75: 570-575.
5. Caplen, N. J., Alton, E. W., Middleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., et al. 1995. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med., 1: 39-46.
6. Chattaraj, S. C. and Das, S. K. 2003. Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles. Drug Deliv., 10: 73-77.
7. Choi, M. J. and Maibach, H. I. 2005. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol. Physiol., 18: 209-219.
8. Devaraj, G. N., Parakh, S. R., Devraj, R., Apte, S. S., Rao, B. R., and Rambhau, D. 2002. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J. Colloid Interface Sci., 251: 360-365.
9. Erdogan, S., Ozer, A. Y., Volkan, B., Caner, B., and Bilgili, H. 2006. Thrombus localization by using streptokinase containing vesicular systems. Drug Deliv., 13: 303-309.
10. Heurtault, B., Saulnier, P., Pech, B., Proust, J. E., and Benoit, J. P. 2003. Physico-chemical stability of colloidal lipid particles. Biomaterials, 24: 4283-4300.
11. Huang, Y., Chen, J., Chen, X., Gao, J., and Liang, W. 2008. PEGylated synthetic surfactant vesicles (niosomes):Novel carriers for oligonucleotides. J. Mater. Sci. Mater. Med., 19: 607-614.
12. Huang, Y. Z., Han, G., Wang, H., and Liang, W. Q. 2005a. Cationic niosomes as gene carriers: Preparation and cellular uptake in vitro. Pharmazie, 60: 473-474.
13. Huang, Y. Z., Liang, W. Q., and Yang, V. C. 2005b. Tween non-ionic surfactant vesicles as gene carriers:Preparation and cellular study in vitro. Paper presented at the Symposium of the National Doctoral Academic Forum for Chemical Engineering and Technology, Tianjin University, Tianjin, China.
14. Ishida, T., Harashima, H., and Kiwada, H. 2002. Liposome clearance. Biosci. Rep., 22: 197-224.
15. Jain, S., Singh, P., Mishra, V., and Vyas, S. P. 2005. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett., 101: 41-49.
16. Jain, S. and Vyas, S. P. 2005. Mannosylated niosomes as carrier adjuvant system for topical immunization. J. Pharm. Pharmacol., 57: 1177-1184.
17. Khaksa, G., D'Souza, R., Lewis, S., and Udupa, N. 2000. Pharmacokinetic study of niosome encapsulated insulin. Indian J. Exp. Biol., 38: 901-905.
18. Liu, Y., Yang, S. F., Li, Y., Xu, H., Qin, L., and Tay, J. H. 2004. The influence of cell and substratum surface hydrophobicities on microbial attachment. J. Biotechnol., 110: 251-256.
19. Luciani, A., Olivier, J. C., Clement, O., Siauve, N., Brillet, P. Y., Bessoud, B., Gazeau, F., Uchegbu, I. F., Kahn, E., Frija, G., and Cuenod, C. A. 2004. Glucose-receptor MR imaging of tumors: Study in mice with PEGylated paramagnetic niosomes. Radiology, 231: 135-142.
20. Manosroi, A., Thathang, K., Werner, R. G., Schubert, R., and Manosroi, J. 2008. Stability of luciferase plasmid entrapped in cationic bilayer vesicles. Int. J. Pharm., 356: 291-299.
21. Murdan, S., Gregoriadis, G., and Florence, A. T. 1999. Sorbitan monostearate/polysorbate 20 organogels containing niosomes: A delivery vehicle for antigens? Eur. J. Pharm. Sci., 8: 177-186.
22. Ning, M., Guo, Y., Pan, H., Yu, H., and Gu, Z. 2005. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: Studies in rats. Drug Deliv., 12: 399-407.
23. Pardakhty, A., Varshosaz, J., and Rouholamini, A. 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int. J. Pharm., 328: 130-141.
24. Perrie, Y., Barralet, J. E., McNeil, S., and Vangala, A. 2004. Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route. Int. J. Pharm., 284: 31-41.
25. Rentel, C. O., Bouwstra, J. A., Naisbett, B., and Junginger, H. E. 1999. Niosomes as a novel peroral vaccine delivery system. Int. J. Pharm., 186: 161-167.
26. Shi, B., Fang, C. and Pei, Y. 2006. Stealth PEG-PHDCA niosomes: Effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J. Pharm. Sci., 95: 1873-1887.
27. Sihorkar, V. and Vyas, S. P. 2000. Polysaccharide coated niosomes for oral drug delivery: Formulation and in vitro stability studies. Pharmazie, 55: 107-113.
28. Sinyakov, M. S., Dror, M., Lublin-Tennenbaum, T., Salzberg, S., Margel, S., and Avtalion, R. R. 2006. Nanoand microparticles as adjuvants in vaccine design: Success and failure is related to host natural antibodies. Vaccine, 24: 6534-6541.
29. Tasi, L.-M., Liu, D.-Z., and Chen, W.-Y. 2003. Microcalorimetric investigation of the interaction of polysorbate surfactants with unilamellar phosphatidylcholines liposomes. Colloids Surf. A: Physicochem. Eng. Aspects, 213: 7-14.
30. Torchilin, V. P. and Trubetskoy, V. S. 1995. Which polymers can make nanoparticulate drug carriers longcirculating? Adv. Drug Deliv. Rev., 16: 141-155.
31. Uchegbu, I. F. 2000. Synthetic Surfactant Vesicles: Niosomes and Other Non-Phospholipid Vesicular Systems. Amsterdam: Harwood Academic.
32. Uchegbu, I. F. and Vyas, S. P. 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm., 172: 33-70.
33. Vangala, A., Bramwell, V. W., McNeil, S., Christensen, D., Agger, E. M., and Perrie, Y. 2007. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J. Control. Release, 119: 102-110.
34. Vangala, A., Kirby, D., Rosenkrands, I., Agger, E. M., Andersen, P., and Perrie, Y. 2006. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: Characterisation, environmental scanning electron microscopy and immunisation studies in mice. J. Pharm. Pharmacol., 58: 787-799.
35. Varshosaz, J., Pardakhty, A., Hajhashemi, V. I., and Najafabadi, A. R. 2003. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv., 10: 251-262.
36. Vyas, S. P., Singh, R. P., Jain, S., Mishra, V., Mahor, S., Singh, P., Gupta, P. N., Rawat, A., and Dubey, P. 2005. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm., 296: 80-86.
37. Zhang, L. and Granick, S. 2006. How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett., 6: 694-698.